Stocks · Korea
086060
KOSDAQ
GeneBioTech
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER11.25x
PBR0.78x
EPS440 KRW
BPS6,387 KRW
ROE6.51%
Dividend yield1.01%
DPS50 KRW
Payout ratio11.36%
Returns and 52-week range
1W+0.51%
1M+1.43%
3M+14.32%
6M+1.23%
1Y+11.86%
YTD+22.68%
52W high5,990원
52W low3,525원
From 52W high-17.36%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 828억 | 17억 | 15억 | 2.0% |
| 2023 | 795억 | 40억 | 26억 | 5.0% |
| 2024 | 830억 | 38억 | 29억 | 4.6% |
| 2025 | 908억 | 39억 | 38억 | 4.3% |
| Quarterly | ||||
| 2024 4Q | 220억 | 13억 | 7억 | 5.9% |
| 2025 1Q | 228억 | 7억 | 8억 | 3.3% |
| 2025 2Q | 231억 | 9억 | 12억 | 3.9% |
| 2025 3Q | 243억 | 14억 | 10억 | 5.6% |
| 2025 4Q | 205억 | 9억 | 8억 | 4.5% |
| 2026 1Q | 215억 | 8억 | 6억 | 3.5% |
Company
Address: 충청남도 공주시 계룡면 신원사로 166
Peers in the same sector
Recent filings
- 2026-08-14반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.